Overview

DUTCH Weight Control in Atrial Fibrillation Study

Status:
Not yet recruiting
Trial end date:
2027-05-01
Target enrollment:
Participant gender:
Summary
Quantify the effect of an innovative weight loss management on rhythm control.
Phase:
Phase 4
Details
Lead Sponsor:
Rijnstate Hospital
Treatments:
Semaglutide